Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer

We tested the prognostic relevance of metabolic parameters and their relative changes in patients with metastatic colorectal cancer (mCRC) treated with monoclonal antibody and chemotherapy. SUV(max) (standardized uptake volume), SAM (standardized added metabolic activity) and TLG (total lesion glyco...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemeth, Zsuzsanna, Wijker, Wouter, Lengyel, Zsolt, Hitre, Erika, Borbely, Katalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772167/
https://www.ncbi.nlm.nih.gov/pubmed/32661836
http://dx.doi.org/10.1007/s12253-020-00865-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772167/
https://www.ncbi.nlm.nih.gov/pubmed/32661836
http://dx.doi.org/10.1007/s12253-020-00865-5

Ejemplares similares